2026财年业绩指引低于预期 波士顿科学(BSX.US)大跌超15%

Core Viewpoint - Boston Scientific (BSX.US) experienced a significant drop of over 15%, marking its largest intraday decline since March 2020, currently trading at $77.80 [1] Financial Guidance - The company provided its fiscal year 2026 earnings guidance, projecting adjusted earnings per share between $3.43 and $3.49, slightly below the analysts' average expectation of $3.47 [1] - The expected annual sales range is between $22.181 billion and $22.383 billion, which is lower than the analysts' average forecast of $22.368 billion [1]